For many years, Berlin Heart has made a better future possible for children suffering from life-threatening heart diseases. In order to retain its innovative power and market leadership, the company currently invests around 40 percent of annual sales…
In recent months, there has been plenty of buzz generated around the Digitale Versorgung Gesetz (DVG), a new law promising a fast track to reimbursement of digital solutions within the German Statutory Healthcare System (SHI) -- and that buzz is for…
Aignostics, a spin-off from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health, pioneering computational pathology for pharmaceutical research and diagnostics, has announced today the closing of €5m in seed round funding.…
CARE (Corona Accelerated R&D in Europe), supported by Europe’s Innovative Medicines Initiative (IMI), is the largest undertaking of its kind dedicated to discovering and developing urgently needed treatment options for COVID-19.
The initiative is…
A group of researchers from Charité – Universitätsmedizin Berlin have further refined the use of deep brain stimulation in the treatment of obsessive-compulsive disorder. By accurately localizing electrode placement in the brains of patients, the…
Myelo Therapeutics GmbH, a clinical-stage pharmaceutical company focused on developing therapies for cancer supportive care and medical countermeasures (MCM), announced today the successful closing of a multi-million Euro financing round, following…
Infection with the novel coronavirus SARS-CoV-2 follows a highly variable course: some of those infected do not even notice it, while others become so seriously ill that their lives are placed at risk. Scientists from the Berlin Institute of Health…
- Multiyear alliance underpins Randox commitment to increase biochip manufacturing to transform rapid diagnostic testing
- SCIENION AG to integrate its precision dispensing technology to enable Randox to scale-up Biochip manufacturing across the…
The history of the pharmaceutical company Takeda from Japan has been 239 years, for 39 years
Takeda is active in Germany. During this time it has acquired and developed the current locations in Berlin, Oranienburg, Konstanz and Singen. In…
The development of drugs for the treatment of rare diseases is difficult, as is the development of safe methods of diagnosis. Although the number of patients suffering from rare diseases is relatively large, the estimated 8,000 different rare…
